Quantcast

Latest Ischemia Stories

2010-11-17 17:38:56

When cardiac or skeletal muscle is not receiving enough oxygen to meet metabolic demands, a person will experience pain, such as angina, chest pain during a heart attack, or leg pain during a vigorous sprint. This type of pain is called "ischemic" pain and is sensed in the body by receptors on sensory neurons. It has been suggested that lactic acid, which increases during muscle exertion under conditions where oxygen is low, is a potential mediator of ischemic pain via action at acid sensing...

2010-11-16 19:25:38

American Heart Association meeting report Treatment that included early surgical procedures to open blocked arteries resulted in better blood flow to the heart than aggressive medical treatment alone in patients with both diabetes and heart disease, according to a study presented at the American Heart Association's Scientific Sessions 2010. Previously, researchers in BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) found that over five years there were no fewer deaths...

2010-11-16 19:17:09

University of Cincinnati researchers have discovered a new protein that could be cardioprotective during heart attack, potentially leading to more targeted treatments for patients at risk. These findings are being presented at the American Heart Association's (AHA) Scientific Sessions in Chicago Nov. 16. Researchers in the department of pharmacology and cell biophysics, led by Wen Zhao, PhD, and Chi Keung Lam, a PhD student, under the direction of Litsa Kranias, PhD, AHA distinguished...

2010-11-15 11:00:00

SAN DIEGO, Nov. 15, 2010 /PRNewswire/ -- Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling...

2010-11-15 08:00:00

SAN DIEGO, Nov. 15, 2010 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) reported on the presentation of results from the Company's sponsored preclinical research at the American Heart Association 2010 Annual Meeting Scientific Sessions being held November 13 - 17, 2010 in Chicago, IL. The new findings showed that coronary artery occlusion and reperfusion can substantially increase adenovector-mediated gene delivery to the heart, which is used in the Company's Generx product...

2010-11-11 08:00:11

(Ivanhoe Newswire)-- Understanding the cause of ischemic stroke, the most common type of stroke, and having the potential of speeding the delivery of life-saving treatments, may all be possible with multidetector computed tomography (CT). "Our results suggest that multidetector CT could become the first-line imaging tool for identifying the cause of acute ischemic stroke," Loic Boussel, the study's lead author, M.D., Ph.D., professor of radiology at Louis Pradel Hospital in Bron, France, was...

2010-11-08 15:06:48

Research led by Dr. Nicolas Bazan, Boyd Professor, Villere Chair, and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center, has shown that Docosahexaenoic acid (DHA), a component of fish oil, is a powerful therapeutic agent that can protect brain tissue and promote recovery in an experimental model of acute ischemic stroke, even when treatment is delayed by up to five hours. These findings not only target a new stroke treatment approach, but also provide vital...

2010-11-02 07:00:00

PORTOLA VALLEY, Calif., Nov. 2, 2010 /PRNewswire/ -- Spectros Corporation presented new clinical results using tissue oxygen saturation with the T-Stat VLS Tissue Oximeter at the San Diego Convention Center during Anesthesiology 2010. This newly released data was presented during poster sessions entitled "Experimental Circulation: Ischemia and Reperfusion" and "Clinical Circulation: Pharmacology/Physiology", held at the American Society of Anesthesiologists (ASA 2010) on October 16, 2010...

2010-10-22 14:12:55

Statement highlights:     * Measures to avoid a second or subsequent stroke include treating metabolic syndrome and undergoing carotid angioplasty.    * Standard antiplatelet drug therapies are equally effective; so a tailored treatment regimen is advised based on individual risk factors and characteristics. Treating metabolic syndrome and undergoing carotid angioplasty may prevent recurrent stroke or transient ischemic attack (TIA), according to revised American...

2010-10-08 06:00:00

MOUNTAIN VIEW, Calif., Oct. 8 /PRNewswire/ -- Concentric Medical, Inc. today announced the full European launch of Trevo(TM), the first device utilizing Stentriever(TM) technology for clot retrieval in ischemic stroke patients. Trevo is the newest offering in a portfolio of products from Concentric Medical, the company that first introduced retrievers for acute ischemic stroke. The Trevo's stent-like design leverages the company's long history of developing clot retrieval technologies for...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related